Merck Sharp & Dohme Corp. v. Ajanta Pharma Limited et al
| Merck Sharp & Dohme Corp. |
| Ajanta Pharma Limited and Ajanta Pharma USA Inc. |
| 1:2020cv00815 |
| June 17, 2020 |
| U.S. District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
This docket was last retrieved on August 7, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: #1 Certification)(Bilson, David) Modified on 8/7/2020 (nms). |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Carolyn A. Blessing and Christopher J. Cassella - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: #1 Certification, #2 Certification, #3 Certification)(Bilson, David) Modified on 8/7/2020 (nms). |
| Pro Hac Vice Attorneys Michael J. Gaertner, Carolyn A. Blessing, Christopher J. Cassella, David B. Abramowitz for Ajanta Pharma Limited and Ajanta Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz, filed by Ajanta Pharma USA Inc., Ajanta Pharma Limited. Signed by Judge Richard G. Andrews on 8/7/2020. (nms)
|
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Carolyn A. Blessing and Christopher J. Cassella, filed by Ajanta Pharma USA Inc., Ajanta Pharma Limited. Signed by Judge Richard G. Andrews on 8/7/2020. (nms)
|
| Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ajanta Pharma Limited. (Phillips, John) |
| Filing 9 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ajanta Pharma Limited for Ajanta Pharma USA Inc. filed by Ajanta Pharma USA Inc.. (Phillips, John) |
| Filing 8 ANSWER to #1 Complaint and Affirmative Defenses, by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Phillips, John) Modified on 7/31/2020 (nms). |
| Filing 7 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Ajanta Pharma USA Inc. waiver sent on 6/19/2020, answer due 8/18/2020. (Silver, Daniel) |
| Filing 6 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Ajanta Pharma Limited waiver sent on 6/19/2020, answer due 8/18/2020. (Silver, Daniel) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than May 6, 2020. Date of Expiration of Patent: November 24, 2026.Thirty Month Stay Deadline: No earlier than 11/6/2022. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT filed against Ajanta Pharma Limited, Ajanta Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3000269.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(myr) |
| No Summons Issued. (myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz, filed by Ajanta Pharma USA Inc., Ajanta Pharma Limited. Signed by Judge Richard G. Andrews on 8/7/2020. (nms)